Skip to main content

Aidoc Funding Rounds & Valuation History (2021–2026)

Private Valuation & Funding Round Tracker · Aidoc

Aidoc funding rounds & valuation history

Aidoc, the New York and Tel Aviv clinical-AI company whose FDA-cleared algorithms and CARE foundation model flag urgent findings in medical imaging for hospitals. Funding from the Series C (Jul 2021) to the Series E (Apr 2026), sourced to Aidoc, Fierce Healthcare and TechCrunch.

Last updated: (IST). Every figure re-checked against the linked sources that day. Rows: 4 Currency: US$, nominal
⬇ Download CSV Cite this dataset Methodology & status definitions
Last closed round Closed
$150M
$150M Series E, Apr 2026
Raised in rounds listed
$436M
Sum of 4 closed rounds with a disclosed amount (GNF calc.)
Largest round
$150M
Series E, Apr 2026
Closed rounds listed
4
Jul 2021 to Apr 2026

Round history

Newest first. Dashed badges and striped rows are not closed transactions. “—” means the source does not disclose the figure or it cannot be computed on the same basis; see the note in each row.

Showing 4 of 4 rows
Aidoc funding rounds, Jul 2021 to Apr 2026
DateStatusRoundAmountLead / buyerValuationVal. ÷ run-rateSource
Closed round
Series EGeneral Catalyst, SoftBank Vision Fund 2 and NVentures also took part. Total funding passed $500M (Aidoc).
$150M
Goldman Sachs Alternatives (Growth Equity)
Not disclosedNo company valuation stated by the source
—Not disclosedNo run-rate stated in the announcement
Aidoc, 29 Apr 2026Also: Fierce Healthcare, 29 Apr 2026
Closed round
Growth round (Jul 2025)The $150M headline included a $40M revolving credit facility (debt), so $110M of equity is shown and summed (GNF calc.: $150M − $40M).
$110M equity (of $150M incl. credit)
General CatalystWith: Square Peg
Not disclosedNo company valuation stated by the source
—Not disclosedNo run-rate stated in the announcement
Aidoc, 23 Jul 2025Also: Fierce Healthcare, 23 Jul 2025
Closed round
Series D
$110M
TCVWith: Alpha Intelligence Capital
Not disclosedNo company valuation stated by the source
—Not disclosedNo run-rate stated in the announcement
Aidoc, Jun 2022
Closed round
Series C
$66M
General Catalyst
Not disclosedNo company valuation stated by the source
—Not disclosedNo run-rate stated in the announcement
Aidoc, 14 Jul 2021Also: TechCrunch, 14 Jul 2021
Step-up = valuation ÷ the prior closed valuation (GNF calc.), shown only where both figures were stated or reported and neither is a lower bound.

Amount raised in each closed round

Amounts raised (equity), not valuations: Aidoc has not disclosed a valuation for any round.

Sources: Aidoc, Fierce Healthcare, TechCrunch. US$ billions, linear scale.

Timeline

Each round and share sale, oldest first.

  1. 14 Jul 2021 · Closed

    Series C: $66M led by General Catalyst.

  2. Jun 2022 · Closed

    Series D: $110M led by TCV.

  3. 23 Jul 2025 · Closed

    Growth round (Jul 2025): $110M equity (of $150M incl. credit) led by General Catalyst.

  4. 29 Apr 2026 · Closed

    Series E: $150M led by Goldman Sachs Alternatives (Growth Equity).

Still private: Aidoc has not filed for an IPO and has not been acquired.

Cite this dataset

Free to quote with a link back. Copy this citation:

Aidoc Funding Rounds & Valuation History. Private Valuation & Funding Round Tracker, GrowthNavigateFunding.net, updated 14 Nov 2026. https://growthnavigatefunding.net/funding/aidoc/

Download the data

The same 4 rows as the table: numeric US$ columns, empty cells where a figure is not disclosed, and a source URL for every row.

File
aidoc-rounds.csv (UTF-8, comma-separated)
Stable URL
https://growthnavigatefunding.net/wp-content/uploads/2026/11/aidoc-rounds.csv
Columns
id, date, date_precision, status, transaction_type, round, amount_usd_low, amount_usd_high, lead_or_buyer, co_leads, valuation_usd_low, valuation_usd_high, valuation_basis, valuation_to_run_rate_multiple, multiple_bound, multiple_basis, step_up_vs_prior_closed, price_per_share_usd_low, price_per_share_usd_high, shares, source, source_url, other_source_urls, notes, last_updated
Updated
(IST)
⬇ Download CSV

Methodology & status definitions

How each row is labelled and calculated.

Closed round

A primary round announced by the company or confirmed in the press, bringing new money to the company.

Valuation ÷ run-rate

Post-money valuation ÷ the run-rate the company stated in that announcement (GNF calc.). Where the run-rate is “crossed” or “over” a figure, the multiple is shown as “under X×”. No row qualifies here unless shown, so no multiple is invented.

What is not a separate row

Seed to Series B (2016–2020), the $40M revolving credit facility in the Jul 2025 financing (debt), and grants.

Updates & corrections

This page stays at one address and is updated in place; the “Last updated” date above drives the citation and the dataset metadata. Corrections: hello@growthnavigatefunding.net. Informational only; not investment advice.

Changelog

  • : Dataset first compiled (AI-50 batch, not yet published).

Sources

  1. Aidoc: Aidoc Raises $150 Million Series E Led by Goldman Sachs to Scale Clinical AI, 29 Apr 2026
  2. Fierce Healthcare: Startup Aidoc banks $150M series E backed by Goldman Sachs, 29 Apr 2026
  3. Aidoc: Aidoc Secures $150M for CARE, its Healthcare Foundation Model, 23 Jul 2025
  4. Fierce Healthcare: Clinical AI company Aidoc lands $150M backed by General Catalyst, Nvidia’s venture arm, 23 Jul 2025
  5. Aidoc: Aidoc raises $110M in Series D Round to Expand AI Care Platform, Jun 2022
  6. Aidoc: Aidoc Raises $66 Million in Series C Round, 14 Jul 2021
  7. TechCrunch: Aidoc raises over $66M for AI radiology analysis technology, 14 Jul 2021